PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer
Azad, Abul; Arshad, Maryam; Generali, Daniele; Feldinger, Katharina; Gijsen, Merel; Strina, Carla; Cappelletti, Mariarosa; Andreis, Daniele; Leek, Russell; Haider, Syed; Kellokumpu-Lehtinen, Pirkko Liisa; Roxanis, Ioannis; Harris, Adrian Llewellyn; Shaaban, Abeer Mahmoud; Joensuu, Heikki; Kong, Anthony (2024)
Azad, Abul
Arshad, Maryam
Generali, Daniele
Feldinger, Katharina
Gijsen, Merel
Strina, Carla
Cappelletti, Mariarosa
Andreis, Daniele
Leek, Russell
Haider, Syed
Kellokumpu-Lehtinen, Pirkko Liisa
Roxanis, Ioannis
Harris, Adrian Llewellyn
Shaaban, Abeer Mahmoud
Joensuu, Heikki
Kong, Anthony
2024
Cancer Communications
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-202501141379
https://urn.fi/URN:NBN:fi:tuni-202501141379
Kuvaus
Non peer reviewed
Kokoelmat
- TUNICRIS-julkaisut [20711]